This indicated that the microfluidic CTC isolation from the SF may potentially have prognostic value in PCa risk stratification and treatment, particularly as an alternative to the PSA test, known for its notoriously poor sensitivity. This evidence concerns the gene KLK3 and posterior cortical atrophy.